Speciality chemicals manufacturer Ashland is facing renewed calls to put itself up for sale after activist investor Cruiser Capital Advisors urged the company’s board to begin a formal strategic review, according to a report by Bloomberg.
In a letter sent to directors on Wednesday, Cruiser Capital argued that Ashland’s portfolio of businesses would generate greater value under new ownership. The investment firm believes the company lacks the scale needed to maximise returns as an independent pub...
Continue Reading
Sign up for FREE to read the full article and access 131K+ alternative investment headlines.